ProteoMediX

ProteoMediX

Identification of novel biomarkers for the early detection of cancer. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD31—47m (Dealroom.co estimates Aug 2018.)
Company register number CHE-115.542.635
Schlieren Switzerland (HQ)
Authorizing premium user...